• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似心脏淀粉样变性患者行 99mTc-HMDP 闪烁显像时心脏摄取的半定量指标。

Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.

机构信息

Nuclear Medicine Unit, Careggi University Hospital, Florence, Italy.

Cardiovascular and Thoracic Department, Careggi University Hospital, Florence, Italy.

出版信息

J Nucl Cardiol. 2021 Feb;28(1):90-99. doi: 10.1007/s12350-019-01643-w. Epub 2019 Feb 14.

DOI:10.1007/s12350-019-01643-w
PMID:30767162
Abstract

BACKGROUND

99mTc-HMDP scintigraphy has proved its efficacy in non-invasive diagnosis of cardiac amyloidosis (CA) and is currently interpreted according to the Perugini qualitative assessment. Several semi-quantitative indices have been proposed to overcome inherent possible limitations of visual grading. Our aim was to comparatively evaluate six different indices and their diagnostic performance.

METHODS

We retrospectively reviewed scintigraphy of 76 patients (53 ATTR, 12 AL, 11 LVH) who underwent diagnostic evaluation at our centre. ROC-curve analysis was performed to identify optimal cut-off and relative diagnostic accuracy of six different indices (of which one was proposed for the first time), both in identifying CA patients and in discriminating patients according to their Perugini score.

RESULTS

Heart/Whole-body ratios proved to be the most accurate (100%) in identifying CA patients. Heart/Pelvis ratio (with soft tissue background correction) offered acceptable accuracy (98%), with the largest area under the curve (AUC) (0.98) in discriminating patients with Perugini ≥ 2. Heart/Contralateral Lung ratio confirmed to be exposed to confounding background noise in case of simultaneous lung uptake. Heart/Skull ratio had the worst performance, with six false-negative patients in ATTR identification.

CONCLUSION

Heart/Whole-body ratios may be robust and effective semi-quantitative indices for the evaluation of CA by means of scintigraphy.

摘要

背景

99mTc-HMDP 闪烁显像已被证明可有效用于非侵入性诊断心脏淀粉样变性(CA),目前根据佩鲁吉尼(Perugini)定性评估进行解读。为了克服视觉分级固有的潜在局限性,已经提出了几种半定量指标。我们的目的是比较评估六种不同的指标及其诊断性能。

方法

我们回顾性分析了在我们中心接受诊断评估的 76 例患者(53 例ATTR,12 例 AL,11 例 LVH)的闪烁显像。通过 ROC 曲线分析,确定了六种不同指标(其中一种是首次提出)的最佳截断值和相对诊断准确性,用于识别 CA 患者以及根据 Perugini 评分对患者进行区分。

结果

心脏/全身比值在识别 CA 患者方面是最准确的(100%)。心脏/骨盆比值(具有软组织背景校正)具有可接受的准确性(98%),在区分 Perugini≥2 的患者方面具有最大的曲线下面积(AUC)(0.98)。心脏/对侧肺比值在同时存在肺摄取的情况下,被证实易受到背景噪声的干扰。心脏/颅骨比值的表现最差,在识别ATTR 患者时,有 6 例出现假阴性。

结论

心脏/全身比值可能是闪烁显像评估 CA 的稳健有效的半定量指标。

相似文献

1
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.疑似心脏淀粉样变性患者行 99mTc-HMDP 闪烁显像时心脏摄取的半定量指标。
J Nucl Cardiol. 2021 Feb;28(1):90-99. doi: 10.1007/s12350-019-01643-w. Epub 2019 Feb 14.
2
Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.(99m)Tc-HMDP 闪烁显像用于心脏淀粉样变性的病因诊断和预后判断的价值。
Amyloid. 2015;22(4):210-20. doi: 10.3109/13506129.2015.1072089. Epub 2015 Oct 14.
3
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.99mTc-羟甲基二膦酸盐闪烁显像诊断转甲状腺素心脏淀粉样变性准确性的研究。
J Nucl Cardiol. 2019 Apr;26(2):497-504. doi: 10.1007/s12350-017-0922-z. Epub 2017 May 23.
4
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.99mTc-羟甲基膦酸盐闪烁显像时 TTR 心脏淀粉样变患者的肺部摄取:被低估的现象。
Int J Cardiol. 2018 Mar 1;254:346-350. doi: 10.1016/j.ijcard.2017.10.027. Epub 2018 Jan 28.
5
Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.99mTc-DPD 闪烁显像的佩鲁吉尼分级在转甲状腺素(ATTR)淀粉样变性中的预后价值及其与骨骼肌和软组织淀粉样变的关系。
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1344-1350. doi: 10.1093/ehjci/jew325.
6
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.骨闪烁显像检测 Phe64Leu 突变相关转甲状腺素蛋白心脏淀粉样变的灵敏度低。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1314-1321. doi: 10.1016/j.jcmg.2019.10.015. Epub 2019 Dec 18.
7
Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.锝[99mTc]羟甲基二膦酸盐骨闪烁扫描术可早期诊断转甲状腺素蛋白衍生的系统性淀粉样变患者的心脏受累。
Amyloid. 2014 Mar;21(1):35-44. doi: 10.3109/13506129.2013.871250. Epub 2014 Jan 23.
8
Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.3,3-二膦酰基-1,2-丙二酸闪烁扫描术在系统性淀粉样变性中的应用及局限性
Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1289-98. doi: 10.1093/ehjci/jeu107. Epub 2014 Jun 16.
9
Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.早期Tc-HMDP SPECT/CT显示的心外软组织摄取有助于心脏淀粉样变性的分型,并具有较高的预后价值。
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2396-2406. doi: 10.1007/s00259-020-04753-7. Epub 2020 Mar 10.
10
New quantitative indices of cardiac amyloidosis with Tc-pyrophosphate scintigraphy.利用锝-焦磷酸盐闪烁扫描术评估心脏淀粉样变的新定量指标。
Jpn J Radiol. 2023 Apr;41(4):428-436. doi: 10.1007/s11604-022-01364-0. Epub 2022 Nov 30.

引用本文的文献

1
[Tc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients.软组织中[Tc]Tc-羟膦酸盐摄取与皮下腹部脂肪组织中的淀粉样蛋白负荷以及野生型转甲状腺素蛋白淀粉样变性患者的死亡率相关。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):88-97. doi: 10.1007/s00259-024-06865-w. Epub 2024 Aug 8.
2
Cardiac [Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?遗传性转甲状腺素蛋白淀粉样变性患者骨骼闪烁显像时心脏 [Tc]Tc-羟膦酸盐摄取:早期随访标志物?
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):681-690. doi: 10.1007/s00259-023-06459-y. Epub 2023 Oct 16.
3

本文引用的文献

1
National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy.用于诊断心脏淀粉样变性的影像学检查利用的全国模式:聚焦于锝99m焦磷酸盐闪烁扫描术。
J Nucl Cardiol. 2017 Jun;24(3):1094-1097. doi: 10.1007/s12350-016-0478-3. Epub 2016 Mar 25.
Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.在患有心脏淀粉样变性的患者中,Tc-99m DPD 和 Tc-99m PYP 闪烁显像的诊断和临床价值的直接比较。
BMC Med Imaging. 2023 Jul 17;23(1):92. doi: 10.1186/s12880-023-01054-x.
4
Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.用于转甲状腺素蛋白心脏淀粉样变性的骨闪烁成像的诊断准确性:系统评价和荟萃分析。
J Nucl Cardiol. 2023 Dec;30(6):2464-2476. doi: 10.1007/s12350-023-03297-1. Epub 2023 May 24.
5
Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.用特立氟胺治疗转甲状腺素蛋白心脏淀粉样变患者后的 Tc-99m 焦磷酸盐心脏扫描随访。
Jpn J Radiol. 2023 Aug;41(8):882-888. doi: 10.1007/s11604-023-01403-4. Epub 2023 Mar 15.
6
Reaction of Pertechnetate in Highly Alkaline Solution: Synthesis and Characterization of the Nitridotrioxotechnetate Ba[TcO N].高碱性溶液中高锝酸盐的反应:氮氧化三氧锝酸盐Ba[TcO₃N]的合成与表征
Chemistry. 2022 Nov 11;28(63):e202201738. doi: 10.1002/chem.202201738. Epub 2022 Sep 12.
7
Radiopharmaceutical supply disruptions and the use of Tc-hydroxymethylene diphosphonate as an alternative to Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.放射性药物供应中断以及使用锝-羟基亚甲基二膦酸盐替代锝-焦磷酸盐用于转甲状腺素蛋白心脏淀粉样变的诊断:一份美国核医学与分子影像学会信息声明。
J Nucl Cardiol. 2022 Oct;29(5):2748-2760. doi: 10.1007/s12350-022-03059-5. Epub 2022 Jul 15.
8
Quantitative Tc-DPD-SPECT/CT assessment of cardiac amyloidosis.定量 Tc-DPD-SPECT/CT 评估心脏淀粉样变性。
J Nucl Cardiol. 2023 Feb;30(1):101-111. doi: 10.1007/s12350-022-02960-3. Epub 2022 May 13.
9
Performance of bone tracer for diagnosis and differentiation of transthyretin cardiac amyloidosis: a systematic review and meta-analysis.用于诊断和鉴别转甲状腺素蛋白心脏淀粉样变性的骨示踪剂的性能:系统评价和荟萃分析。
Diagn Interv Radiol. 2021 Nov;27(6):802-810. doi: 10.5152/dir.2021.20662.
10
Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.CMR、SPECT 和 PET 成像在心脏淀粉样变性检测中的诊断性能:荟萃分析。
BMC Cardiovasc Disord. 2021 Oct 7;21(1):482. doi: 10.1186/s12872-021-02292-z.